POLYMEROPOULOS, MIHAEL H.,BAROLDI, PAOLO,WOLFGANG, CURT D.
申请号：
CA2709104
公开号：
CA2709104C
申请日:
2008.12.13
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The subject invention provides the use of a therapeutically effective amountof4-[3-[4(6-fluoro-1,2,-benzisoxazol-3-yI)-1-piperidinyl]propoxy]-3-methoxy-benzoic acid orpharmaceutically-acceptable salt thereof (in a controlled or sustained releasepharmaceutical dosage form) for antagonizing a 5-HT2A receptor in an animalsufferinga condition that is mediated by a 5-HT2A receptor.
